Propiedad y actividad de insiders de Novavax, Inc. (NVAX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $9.35 |
| Capitalización | $1.5B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-06-20 | Rodgers Richard J | M-Exempt | 18,880 | |
| 2026-06-18 | Rodgers Richard J | A-Award | 21,270 | $194K |
| 2026-06-18 | Rodgers Richard J | A-Award | 14,180 | |
| 2026-06-20 | Rodgers Richard J | M-Exempt | 18,880 | |
| 2026-06-20 | King Rachel K. | M-Exempt | 18,880 | |
| 2026-06-18 | King Rachel K. | A-Award | 21,270 | $194K |
| 2026-06-18 | King Rachel K. | A-Award | 14,180 | |
| 2026-06-20 | King Rachel K. | M-Exempt | 18,880 | |
| 2026-06-20 | DOUGLAS RICHARD | M-Exempt | 18,880 | |
| 2026-06-18 | DOUGLAS RICHARD | A-Award | 21,270 | $194K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $144.4M | $106.3M | $70.2M | $78.8M | $553.4M | $1.52B | $1.34B | $568.5M | $530.2M | $240.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $157.6M | 0 | 0 | 0 | $392.9M | $494.4M |
| Cuentas por Cobrar | $233000 | 0 | 0 | $7.5M | $262.0M | $455.0M | $82.4M | $297.2M | $108.3M | $106.4M |
| Inventario | $15.7M | $13.1M | $12.0M | 0 | 0 | $8.9M | $36.7M | $41.7M | $8.7M | $11.5M |
| Activos Corrientes | $287.8M | $203.3M | $119.3M | $97.2M | $1.25B | $2.16B | $1.70B | $1.14B | $1.13B | $978.3M |
| Inmovilizado Material | $40.2M | $36.0M | $28.4M | $11.4M | $180.0M | $228.7M | $400.5M | $491.0M | $300.0M | $67.7M |
| Fondo de Comercio | $51.7M | $53.6M | $52.0M | $51.2M | $135.4M | $131.5M | $126.3M | $127.5M | $107.5M | $113.5M |
| Activos Intangibles | $9.2M | $7.9M | $6.5M | $5.6M | $5.7M | $4.8M | 0 | 0 | 0 | 0 |
| Activos Totales | $394.3M | $302.5M | $208.0M | $173.0M | $1.58B | $2.58B | $2.26B | $1.80B | $1.56B | $1.18B |
| Cuentas por Pagar | $5.7M | $5.6M | $9.3M | $2.9M | $54.3M | $127.0M | $216.5M | $132.6M | $41.6M | $24.6M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $324.9M | 0 | 0 | 0 |
| Pasivos Corrientes | $66.4M | $73.7M | $45.5M | $25.8M | $579.7M | $2.39B | $2.46B | $1.64B | $1.15B | $459.9M |
| Deuda a Largo | $316.3M | $317.8M | $319.2M | $320.6M | $322.0M | $323.5M | $166.5M | $168.0M | $169.7M | $244.2M |
| Pasivos Totales | $399.8M | $404.2M | $375.9M | $359.0M | $955.3M | $2.93B | $2.89B | $2.51B | $2.18B | $1.30B |
| Reservas | -$930.0M | -$1.11B | -$1.30B | -$1.43B | -$1.87B | -$3.62B | -$4.28B | -$4.82B | -$5.01B | -$4.57B |
| Patrimonio Neto | -$5.5M | -$101.7M | -$167.9M | -$186.0M | $627.2M | -$351.7M | -$634.1M | -$716.9M | -$623.8M | -$127.8M |
| Deuda Total | $316.3M | $317.8M | $319.2M | $321.9M | $468.0M | $454.0M | $549.8M | $229.1M | $230.4M | $248.8M |
| Deuda Neta | $172.0M | $211.5M | $249.0M | $243.1M | -$243.1M | -$1.06B | -$787.1M | -$339.4M | -$692.7M | -$486.3M |
| Capital Circulante | $221.4M | $129.6M | $73.7M | $71.5M | $668.5M | -$235.2M | -$756.6M | -$491.2M | -$25.5M | $518.3M |
Salud financiera
| Deuda / Patrimonio | -1.55 |
| Ratio corriente | 2.33 |
Rentabilidad
| Rentabilidad sobre capital | 159.85% |
| Rentabilidad sobre capital invertido | -36.14% |
| Rentabilidad sobre activos | -25.92% |
| Margen bruto | 77.85% |
| Margen operativo | -54.94% |
| Margen neto | -59.87% |
Empresas relacionadas: CVAC · NKTR · NTLA · ORIC · PGEN · TERN · TRVI
Explorar sector: Healthcare · Biotechnology
Más secciones de NVAX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones